Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 503 clinical trials
featured
A double blind placebo controlled multicenter study of investigational medication as adjunctive treatment to a antidepressant in adults with Major Depressive Disorder.

A double blind placebo controlled multicenter study of investigational medication as adjunctive treatment to a antidepressant in adults with Major Depressive Disorder.

  • 578 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole as Adjunctive Therapy in the Maintenance Treatment of Adults With Major Depressive Disorder

Brexpiprazole is a medication being studied as a possible treatment for adjunctive treatment for Major Depressive Disorder (MDD). It was first approved in the United States for the treatment of

  • 0 views
  • 06 Apr, 2021
  • 1 location
featured
A Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Subjects With Comorbid Major Depressive Disorder and Insomnia

This study is a randomized, double-blind, placebo-controlled study of the safety, tolerability, and efficacy of SAGE-217 compared to placebo in adult subjects with comorbid major depressive

major depressive disorder
  • 200 views
  • 27 Jun, 2019
  • 2 locations
featured
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexipiprazole as Adjunctive Therapy in the Maintenance of Adults With Major Depressive Disorder

A study to compare the efficacy of brexpiprazole to placebo as adjunctive therapy to antidepressant therapy for the maintenance treatment in adults with major depressive disorder.  

depressive disorder
antidepressant therapy
  • 75 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, Tolerability and Pharmacokinetics of JNJ-XXX in Subjects with Major Depressive Disorder

A study to evaluate the efficacy of JNJ-XXX compared to placebo when administered as adjunctive treatment in subjects with MDD partially responsive to SSRI/SNRI treatment in terms of reduction of

selective serotonin reuptake inhibitors
depressive symptoms
depressed mood
  • 56 views
  • 23 Nov, 2020
  • 1 location
featured
Depression

Major depressive disorder (MDD), more commonly referred to as depression, is more than just a sad mood or feeling down. The newest research suggests that the symptoms of depression may be due to

behavior therapy
depressed mood
suicidal
depressive symptoms
depressive disorder
  • 16 views
  • 30 Jul, 2021
  • 1 location
featured
A Double-Blind, Placebo-Controlled Study of Cariprazine as an Adjunct to Antidepressants in the Treatment of Patients With Major Depressive Disorder Who Have Had an Indadequate Response to Antidepressants Alone

A study to evaluate the efficacy, safety, and tolerability of cariprazine compared with placebo as an adjunctive treatment to ongoing antidepressant therapy in patients with major depressive

antidepressants
depressive disorder
antidepressant therapy
  • 94 views
  • 23 Nov, 2020
  • 1 location
featured
Study Seeking Patients with Depression

Study Seeking Patients with Depression

  • 562 views
  • 25 Mar, 2021
  • 1 location
featured
Depressed?

Depressed?

  • 860 views
  • 08 Nov, 2020
  • 1 location
featured
Outpatient study for an investigational medication for depression

Outpatient study for an investigational medication for depression

  • 1092 views
  • 08 Nov, 2020
  • 1 location